Michela Puxeddu

9PUBLICATIONS
18CO-AUTHORS
Organometallic chemistryCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsBiologically active moleculesBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 12, 2026
(S,S)-5-Chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(1-oxo-1-((1-(pyridin-4-yl)ethyl)amino)propan-2-yl)-1H-indole-2-carboxamide, a New Dishevelled 1 and P-Glycoprotein Dual Inhibitor as a Anticancer Agent.

|Mar 25, 2026
Correction to "Ferroptosis Induction by a New Pyrrole Derivative in Triple Negative Breast Cancer and Colorectal Cancer".

Domiziana Masci, Lele Ling, Lian Yang

|Sep 13, 2025
Metabolism, a Blossoming Target for Small-Molecule Anticancer Drugs.

Michela Puxeddu, Romano Silvestri, Giuseppe La Regina

|Aug 11, 2025
Ferroptosis Induction by a New Pyrrole Derivative in Triple Negative Breast Cancer and Colorectal Cancer.

Domiziana Masci, Lele Ling, Lian Yang

|Apr 17, 2025
Correction to "Novel N-(Heterocyclylphenyl)benzensulfonamide Sharing an Unreported Binding Site with T-Cell Factor 4 at the β-Catenin Armadillo Repeats Domain as Anticancer Agent".

Marianna Nalli, Laura Di Magno, Yichao Wen

|Nov 07, 2024
Development of N-(4-(1H-Imidazol-1-yl)phenyl)-4-chlorobenzenesulfonamide, a Novel Potent Inhibitor of β-Catenin with Enhanced Antitumor Activity and Metabolic Stability.

Michela Puxeddu, Lele Ling, Silvia Ripa

Pageof 2

Frequent Collaborators

9 joint publications

Romano Silvestri

9 joint publications

Giuseppe La Regina

6 joint publications

Giulio Dondio

6 joint publications

Antonio Coluccia